Filed: 2/17/2026ACC: 0001940272-26-000002
📋 What this filing means
ADAR1 CAPITAL MANAGEMENT, LLC filed this quarterly 13F‑HR report disclosing 256 equity positions with a total reported market value of $1.38B. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
256
Positions
$1.38B
Total AUM (reported)
102.81M
Total Shares
Allocation by class
COM$695.44M50.4%
SPONSORED ADS$194.80M14.1%
COM NEW$145.63M10.5%
SHS$101.07M7.3%
ALPHA ARCH 1-3$38.80M2.8%
TR UNIT$37.29M2.7%
CL A ORD SHS$25.50M1.8%
Portfolio Concentration
Top 3$343.69M24.9%
4–10$271.22M19.6%
11–25$255.93M18.5%
Rest$510.30M36.9%
Top 3 weight
24.9%
Top 10 weight
44.5%
Voting Authority Distribution
Total shares with voting rights: 100.50M
Sole
Full voting authority
100.50M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole256
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings256
Rows:
ABIVAX SA
SOLEShares1.32M
TypeSH
Market value$177.65M
12.86%
Sole
1.32M
Shared
0.00
None
0.00
PROTAGONIST THERAPEUTICS INC
SOLEShares1.05M
TypeSH
Market value$91.63M
6.63%
Sole
1.05M
Shared
0.00
None
0.00
ROIVANT SCIENCES LTD
SOLEShares3.43M
TypeSH
Market value$74.41M
5.39%
Sole
3.43M
Shared
0.00
None
0.00
IMMUNOVANT INC
SOLEShares2.48M
TypeSH
Market value$63.07M
4.57%
Sole
2.48M
Shared
0.00
None
0.00
AVIDITY BIOSCIENCES INC
SOLEShares546.53K
TypeSH
Market value$39.42M
2.85%
Sole
546.53K
Shared
0.00
None
0.00
EA SERIES TRUST
SOLEShares337.13K
TypeSH
Market value$38.80M
2.81%
Sole
337.13K
Shared
0.00
None
0.00
SPDR S&P 500 ETF TR
SOLEShares54.68K
TypeSH
Market value$37.29M
2.70%
Sole
54.68K
Shared
0.00
None
0.00
CYTOKINETICS INC
SOLEShares540.17K
TypeSH
Market value$34.32M
2.49%
Sole
540.17K
Shared
0.00
None
0.00
SEPTERNA INC
SOLEShares1.16M
TypeSH
Market value$32.27M
2.34%
Sole
1.16M
Shared
0.00
None
0.00
ARBUTUS BIOPHARMA CORP
SOLEShares5.42M
TypeSH
Market value$26.05M
1.89%
Sole
5.42M
Shared
0.00
None
0.00
PERCEPTIVE CAP SOLUTIONS COR
SOLEShares1.96M
TypeSH
Market value$25.50M
1.85%
Sole
1.96M
Shared
0.00
None
0.00
ZAI LAB LTD
SOLEShares1.25M
TypeSH
Market value$21.99M
1.59%
Sole
1.25M
Shared
0.00
None
0.00
TERNS PHARMACEUTICALS INC
SOLEShares541.62K
TypeSH
Market value$21.88M
1.58%
Sole
541.62K
Shared
0.00
None
0.00
CYTOMX THERAPEUTICS INC
SOLEShares4.28M
TypeSH
Market value$18.24M
1.32%
Sole
4.18M
Shared
0.00
None
0.00
CELLDEX THERAPEUTICS INC NEW
SOLEShares646.77K
TypeSH
Market value$17.57M
1.27%
Sole
646.77K
Shared
0.00
None
0.00
RAPT THERAPEUTICS INC
SOLEShares509.68K
TypeSH
Market value$17.26M
1.25%
Sole
509.68K
Shared
0.00
None
0.00
INHIBIKASE THERAPEUTICS INC
SOLEShares8.06M
TypeSH
Market value$16.53M
1.20%
Sole
8.06M
Shared
0.00
None
0.00
BRIDGEBIO PHARMA INC
SOLEShares213.41K
TypeSH
Market value$16.32M
1.18%
Sole
213.41K
Shared
0.00
None
0.00
MONOPAR THERAPEUTICS INC
SOLEShares233.91K
TypeSH
Market value$15.27M
1.11%
Sole
233.91K
Shared
0.00
None
0.00
FULCRUM THERAPEUTICS INC
SOLEShares1.32M
TypeSH
Market value$14.92M
1.08%
Sole
1.25M
Shared
0.00
None
0.00
VAXCYTE INC
SOLEShares315.64K
TypeSH
Market value$14.56M
1.05%
Sole
315.64K
Shared
0.00
None
0.00
CRINETICS PHARMACEUTICALS IN
SOLEShares309.37K
TypeSH
Market value$14.40M
1.04%
Sole
309.37K
Shared
0.00
None
0.00
PROTHENA CORP PLC
SOLEShares1.46M
TypeSH
Market value$13.92M
1.01%
Sole
1.46M
Shared
0.00
None
0.00
LEXEO THERAPEUTICS INC
SOLEShares1.39M
TypeSH
Market value$13.83M
1.00%
Sole
1.39M
Shared
0.00
None
0.00
TAYSHA GENE THERAPIES INC
SOLEShares2.50M
TypeSH
Market value$13.73M
0.99%
Sole
2.50M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
ABIVAX SASOLE | SPONSORED ADS | 1.32M | SH | $177.65M 12.86% | 1.32M | 0.00 | 0.00 |
PROTAGONIST THERAPEUTICS INCSOLE | COM | 1.05M | SH | $91.63M 6.63% | 1.05M | 0.00 | 0.00 |
ROIVANT SCIENCES LTDSOLE | SHS | 3.43M | SH | $74.41M 5.39% | 3.43M | 0.00 | 0.00 |
IMMUNOVANT INCSOLE | COM | 2.48M | SH | $63.07M 4.57% | 2.48M | 0.00 | 0.00 |
AVIDITY BIOSCIENCES INCSOLE | COM | 546.53K | SH | $39.42M 2.85% | 546.53K | 0.00 | 0.00 |
EA SERIES TRUSTSOLE | ALPHA ARCH 1-3 | 337.13K | SH | $38.80M 2.81% | 337.13K | 0.00 | 0.00 |
SPDR S&P 500 ETF TRSOLE | TR UNIT | 54.68K | SH | $37.29M 2.70% | 54.68K | 0.00 | 0.00 |
CYTOKINETICS INCSOLE | COM NEW | 540.17K | SH | $34.32M 2.49% | 540.17K | 0.00 | 0.00 |
SEPTERNA INCSOLE | COM | 1.16M | SH | $32.27M 2.34% | 1.16M | 0.00 | 0.00 |
ARBUTUS BIOPHARMA CORPSOLE | COM | 5.42M | SH | $26.05M 1.89% | 5.42M | 0.00 | 0.00 |
PERCEPTIVE CAP SOLUTIONS CORSOLE | CL A ORD SHS | 1.96M | SH | $25.50M 1.85% | 1.96M | 0.00 | 0.00 |
ZAI LAB LTDSOLE | ADR | 1.25M | SH | $21.99M 1.59% | 1.25M | 0.00 | 0.00 |
TERNS PHARMACEUTICALS INCSOLE | COM | 541.62K | SH | $21.88M 1.58% | 541.62K | 0.00 | 0.00 |
CYTOMX THERAPEUTICS INCSOLE | COM | 4.28M | SH | $18.24M 1.32% | 4.18M | 0.00 | 0.00 |
CELLDEX THERAPEUTICS INC NEWSOLE | COM NEW | 646.77K | SH | $17.57M 1.27% | 646.77K | 0.00 | 0.00 |
RAPT THERAPEUTICS INCSOLE | COM NEW | 509.68K | SH | $17.26M 1.25% | 509.68K | 0.00 | 0.00 |
INHIBIKASE THERAPEUTICS INCSOLE | COM NEW | 8.06M | SH | $16.53M 1.20% | 8.06M | 0.00 | 0.00 |
BRIDGEBIO PHARMA INCSOLE | COM | 213.41K | SH | $16.32M 1.18% | 213.41K | 0.00 | 0.00 |
MONOPAR THERAPEUTICS INCSOLE | COM NEW | 233.91K | SH | $15.27M 1.11% | 233.91K | 0.00 | 0.00 |
FULCRUM THERAPEUTICS INCSOLE | COM | 1.32M | SH | $14.92M 1.08% | 1.25M | 0.00 | 0.00 |
VAXCYTE INCSOLE | COM | 315.64K | SH | $14.56M 1.05% | 315.64K | 0.00 | 0.00 |
CRINETICS PHARMACEUTICALS INSOLE | COM | 309.37K | SH | $14.40M 1.04% | 309.37K | 0.00 | 0.00 |
PROTHENA CORP PLCSOLE | SHS | 1.46M | SH | $13.92M 1.01% | 1.46M | 0.00 | 0.00 |
LEXEO THERAPEUTICS INCSOLE | COM | 1.39M | SH | $13.83M 1.00% | 1.39M | 0.00 | 0.00 |
TAYSHA GENE THERAPIES INCSOLE | COM SHS | 2.50M | SH | $13.73M 0.99% | 2.50M | 0.00 | 0.00 |
Page 1 of 11
…